Heart rhythm
Authors: Lee CH, Scheinman MM
Heart rhythm
Authors: Xiong N, Gu W, Li J, Scheinman MM
Heart rhythm
Authors: Higuchi S, Gerstenfeld EP, Scheinman MM
Journal of medical virology
Authors: Wiedel NA, Sayles H, Larson J, Wardian JL, Hewlett A, McClay J, Ge J, Anzalone AJ, N3C consortium
Journal of managed care & specialty pharmacy
Authors: Fahim SM, Tice JA, Suh K, Carlson JJ, Richardson M, Chu JN, Herce-Hagiwara B, Agboola F, Rind D, Pearson SD
Journal of acquired immune deficiency syndromes (1999)
Authors: Magnus M, Segarra L, Robinson B, Blankenship K, Corneli A, Ghebremichael M, Irvin N, McIntosh R, Favor KE, Jordan-Sciutto KL, Kimberly J, Sluis-Cremer N, Koethe JR, Newell A, Wood C, Rana A, Stockman JK, Sauceda J, Marquez C, Chi BH, Orellana ER, Wutoh A, Bowleg L, Greenberg AE
Journal of acquired immune deficiency syndromes (1999)
Authors: Greenberg AE, Wutoh A, Bowleg L, Robinson B, Magnus M, Segarra L, Simon P, Wutoh A, Blankenship K, Burke M, Okeke NL, Corneli A, Hussen S, Holliday RC, Ciaranello A, Ghebremichael M, Haberer J, Irvin R, Irvin N, Antoine DG, Chen Z, Momplaisir F, Jordan-Sciutto K, So-Armah K, Kuo C, Flanigan T, Sanchez M, Levine AD, Sluis-Cremer N, Koethe JR, Dash C, Pereira FA, Rice AP, Newell A, Dacus J, Wood C, Elopre L, Rana A, Pitpitan E, Stockman JK, Sauceda J, Marquez C, Robinson S, Chi BH, Balkus J, Walters K, Lewin A, Schoonmaker A, Wong E, Refsland E, CDEIPI Consortium: DC CFAR CDEIPI Coordinating Center:, DC CFAR:, Duke CFAR:, Emory CFAR:, Harvard CFAR:, Johns Hopkins University CFAR:, Miami CFAR:, Penn CFAR:, Providence/Boston CFAR:, Rustbelt CFAR:, Tennessee CFAR:, Texas D-CFAR:, Third Coast CFAR:, UAB CFAR:, San Diego CFAR:, UCSF CFAR:, UNC CFAR:, UW/Fred Hutch CFAR:, NIH CFAR Program Office:
Journal of acquired immune deficiency syndromes (1999)
Authors: Sauceda JA, Watabe J, Sterling L, Fuchs J, Parangan-Smith A, Uwaezuoke K, Gandhi M, Marquez C
Volume 12 of Issue 19 | Journal of the American Heart Association
Authors: Hanna JM, Wang SY, Kochar A, Park DY, Damluji AA, Henry GA, Ahmad Y, Curtis JP, Nanna MG
Background Complex percutaneous coronary intervention (PCI) is increasingly performed in older adults (age ≥75 years) with stable ischemic heart disease. However, little is known about clinical outcomes. Methods and Results We derived a cohort of older adults undergoing elective PCI for stable ischemic heart disease across a large health system. We compared 12-month event-free survival (freedom from all-cause death, nonfatal myocardial infarction, stroke, and major bleeding), all-cause death, target lesion revascularization, and bleeding events for patients receiving complex versus noncomplex PCI and derived risk estimates with Cox regression models. We included 513 patients (mean age, 81±5 years). Patients receiving complex PCI versus noncomplex PCI did not significantly differ across a host of clinical characteristics including cardiovascular disease features, noncardiac comorbidities, guideline-directed medical therapy use, and frailty. Patients receiving complex PCI versus noncomplex PCI experienced worse event-free survival (80.4% versus 86.8%), which was not significant in adjusted analyses (hazard ratio [HR], 1.38 [95% CI, 0.88-2.16]). All-cause death at 1 year for patients undergoing complex PCI was nearly double that seen for patients receiving noncomplex PCI (10.2% versus 5.9%), and the risk was significant in models adjusted for clinical characteristics (HR, 1.97 [95% CI, 1.02-3.79]). Target lesion revascularization risk was lower for patients receiving complex PCI (2.2% versus 3.5%, adjusted HR), but bleeding events were not statistically different between groups (25.3% versus 20.5%; =0.19). Conclusions Complex PCI in older adults with stable ischemic heart disease was associated with lower risk of target lesion revascularization but higher all-cause death compared with noncomplex PCI.
View on PubMed
American Journal of Medicine Open
Authors: Steverson AB, Marano PJ, Chen C, Ma Y, Stern RJ, Feng J, Gennatas ED, Marks JD, Durstenfeld MS, Davis JD, Hsue PY, Zier LS
